ArticlePloS one2025

A disproportionality analysis of insulin glargine in the overall population and in pregnant women using the FDA adverse event reporting system (FAERS) database.

Shaozhi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.